8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors

Details for Australian Patent Application No. 2001273921 (hide)

Owner Novartis AG

Inventors Sandham, David Andrew; Naef, Reto; Gomez, Sylvie Felicite; Fairhurst, Robin Alec; Collingwood, Stephen Paul; Bhalay, Gurdip

Agent Davies Collison Cave

Pub. Number AU-B-2001273921

PCT Pub. Number WO01/77110

Priority 0008694 07.04.00 GB

Filing date 5 April 2001

Wipo publication date 23 October 2001

Acceptance publication date 5 May 2005

International Classifications

C07D 473/06 Heterocyclic compounds containing purine ring systems

A61K 031/52

C07D 239/54 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61P 015/00 Drugs for genital or sexual disorders

Event Publications

5 May 2005 Application Accepted

  Published as AU-B-2001273921

1 September 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001273922

2001273920